OLMESARTAN MEDOXOMIL | A078276 | RISING PHARMA HOLDING INC
Total Spending
$89.2M
Total Claims
2,982,251
Beneficiaries
773,533
Avg Cost/Unit
$0.39
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
28 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Oct 31, 2016 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.